Integrated care for older multimorbid heart failure patients: protocol for the ESCAPE randomized trial and cohort study
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Forlagets udgivne version, 1,07 MB, PDF-dokument
Evaluation of a patient-centred biopsychosocial blended collaborative care pathway for the treatment of multimorbid elderly patients.
Therapeutic Area
Healthcare interventions for the management of older patients with multiple morbidities.
Aims
Multi-morbidity treatment is an increasing challenge for healthcare systems in ageing societies. This comprehensive cohort study with embedded randomized controlled trial tests an integrated biopsychosocial care model for multimorbid elderly patients.
Hypothesis
A holistic, patient-centred pro-active 9-month intervention based on the blended collaborative care (BCC) approach and enhanced by information and communication technologies can improve health-related quality of life (HRQoL) and disease outcomes as compared with usual care at 9 months.
Methods
Across six European countries, ESCAPE is recruiting patients with heart failure, mental distress/disorder plus ≥2 medical co-morbidities into an observational cohort study. Within the cohort study, 300 patients will be included in a randomized controlled assessor-blinded two-arm parallel group interventional clinical trial (RCT). In the intervention, trained care managers (CMs) regularly support patients and informal carers in managing their multiple health problems. Supervised by a clinical specialist team, CMs remotely support patients in implementing the treatment plan—customized to the patients' individual needs and preferences—into their daily lives and liaise with patients' healthcare providers. An eHealth platform with an integrated patient registry guides the intervention and helps to empower patients and informal carers.
HRQoL measured with the EQ-5D-5L as primary endpoint, and secondary outcomes, that is, medical and patient-reported outcomes, healthcare costs, cost-effectiveness, and informal carer burden, will be assessed at 9 and ≥18 months.
Conclusions
If proven effective, the ESCAPE BCC intervention can be implemented in routine care for older patients with multiple morbidities across the participating countries and beyond.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | ESC heart failure |
| Vol/bind | 10 |
| Udgave nummer | 3 |
| Sider (fra-til) | 2051-2065 |
| Antal sider | 15 |
| ISSN | 2055-5822 |
| DOI | |
| Status | Udgivet - 2023 |
Bibliografisk note
Funding Information:
The intervention is supported by the developed by the Digital Health department of the Fraunhofer Institute for Applied Information Technology FIT. For an impression of imergo®, see ; for more details, see . imergo® e‐health Integrated Care Platform (ICP) Figure 2 Appendix S2
Funding Information:
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement no. 945377 (ESCAPE). This output reflects the views of the authors, and the European Commission is not responsible for any use that may be made of the information contained therein.
Funding Information:
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement no. 945377 (ESCAPE). This output reflects the views of the authors, and the European Commission is not responsible for any use that may be made of the information contained therein. The University of Göttingen Medical Center serves the legal role of a study sponsor. We acknowledge support by the Open Access Publication Funds of the Göttingen University. Open Access funding enabled and organized by Projekt DEAL.
Funding Information:
The University of Göttingen Medical Center serves the legal role of a study sponsor. We acknowledge support by the Open Access Publication Funds of the Göttingen University.
Publisher Copyright:
© 2023 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
ID: 366384072